| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32a0a0d7d646ae30d934ea016a31be69 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-756
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-296
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-756
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-296
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-481 |
| filingDate |
2003-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b122a0226fc8a6a07d94b2bd0593b14a |
| publicationDate |
2005-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20050084420-A |
| titleOfInvention |
A medicament containing epidemium extract for treatment of prostatic hyperplasia and prostatitis |
| abstract |
The present invention relates to a pharmaceutical composition for treating hyperplasia of the prostate and for treating prostatitis. The pharmaceutical composition comprises flavonoids and polysaccharides extracted from the marine medicinal materials at a weight ratio of 2-8: 8-2, wherein the flavonoids contain 20-90% of flavones and the molecular weight of the polysaccharides is 1000-700,000 daltons. The dried roots of Panax ginseng, the pollen, the dried roots of Astragalus membranaceus or Astragalus membranaceus mongholicus, the roots of Pelodendron chinensis Extracts extracted from the dry roots of Phellodendron chinese or Phellodendron amurense may be added as active ingredients. The pharmaceutical composition has no side effects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101144991-B1 |
| priorityDate |
2002-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |